For Marti Jett, the chief of molecular pathology at Walter Reed Army Institute of Research in Silver Spring, Md., catching things early is essentially part of her job description. As an Army researcher, she’s interested in finding ways to rapidly identify patients who have been exposed to pathogens that could be used in warfare. By the time a patient is clinically diagnosed with anthrax, for example, estimates are that person has only a 12 percent chance of beating the disease when treated with the antibiotic ciproflaxin.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.